Franzoni et al., 2020 - Google Patents
Comparison of macrophage responses to African swine fever viruses reveals that the NH/P68 strain is associated with enhanced sensitivity to type I IFN and cytokine …Franzoni et al., 2020
View HTML- Document ID
- 16395867234136564707
- Author
- Franzoni G
- Razzuoli E
- Dei Giudici S
- Carta T
- Galleri G
- Zinellu S
- Ledda M
- Angioi P
- Modesto P
- Graham S
- Oggiano A
- Publication year
- Publication venue
- Pathogens
External Links
Snippet
African swine fever (ASF) poses a severe threat to the global pig industry for which currently there is no available vaccine. The aetiological ASF virus (ASFV) has a predilection for cells of the myeloid lineage, however little is known about its interaction with polarised …
- 210000002540 Macrophages 0 title abstract description 129
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving viable micro-organisms
- C12Q1/025—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving viable micro-organisms for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Franzoni et al. | Comparison of macrophage responses to African swine fever viruses reveals that the NH/P68 strain is associated with enhanced sensitivity to type I IFN and cytokine responses from classically activated macrophages | |
Wu et al. | Current state of global African swine fever vaccine development under the prevalence and transmission of ASF in China | |
Ramirez-Medina et al. | Differential effect of the deletion of African swine fever virus virulence-associated genes in the induction of attenuation of the highly virulent Georgia strain | |
Zhang et al. | Deletion of the L7L-L11L genes attenuates ASFV and induces protection against homologous challenge | |
Schountz | Immunology of bats and their viruses: challenges and opportunities | |
Razzuoli et al. | Modulation of type I interferon system by African swine fever virus | |
Bo et al. | A review of pseudorabies virus variants: genomics, vaccination, transmission, and zoonotic potential | |
Han et al. | Infectious bronchitis virus infection induces apoptosis during replication in chicken macrophage HD11 cells | |
Pershin et al. | A long-term study of the biological properties of ASF virus isolates originating from various regions of the Russian Federation in 2013–2018 | |
Deutschmann et al. | Taking a promising vaccine candidate further: efficacy of ASFV-G-ΔMGF after intramuscular vaccination of domestic pigs and Oral vaccination of wild boar | |
Shi et al. | The emergence of a vv+ MDV can break through the protections provided by the current vaccines | |
Tang et al. | Identification of the immediate-early genes of cyprinid herpesvirus 2 | |
Zhou et al. | Synergistic viral replication of Marek’s disease virus and avian leukosis virus subgroup J is responsible for the enhanced pathogenicity in the superinfection of chickens | |
Bertzbach et al. | IFNα and IFNγ Impede Marek’s Disease Progression | |
Baj et al. | Viral infections in burn patients: a state-of-the-art review | |
Michelitsch et al. | In vivo characterization of tick-borne encephalitis virus in bank voles (Myodes glareolus) | |
Gao et al. | The African swine fever virus with MGF360 and MGF505 deleted reduces the apoptosis of porcine alveolar macrophages by inhibiting the NF-κB signaling pathway and interleukin-1β | |
Canter et al. | Serum neutralizing and enhancing effects on African swine fever virus infectivity in adherent pig PBMC | |
Franzoni et al. | Analyses of the impact of immunosuppressive cytokines on porcine macrophage responses and susceptibility to infection to African swine fever viruses | |
Zhang et al. | Vaccination with Omicron inactivated vaccine in pre-vaccinated mice protects against SARS-CoV-2 prototype and Omicron variants | |
Fan et al. | Host responses to live-attenuated ASFV (HLJ/18–7GD) | |
Zhou et al. | Isolation and characterization of two pseudorabies virus and evaluation of their effects on host natural immune responses and pathogenicity | |
Cano et al. | Seroconversion and skin mucosal parameters during koi herpesvirus shedding in common carp, Cyprinus carpio | |
Anderson et al. | Effect of viral strain and host age on clinical disease and viral replication in immunocompetent mouse models of Chikungunya Encephalomyelitis | |
Sato et al. | Effect of insertion and deletion in the Meq Protein encoded by highly Oncogenic Marek’s disease virus on transactivation activity and virulence |